Abstract |
The prevention of metastasis is a central goal of cancer therapy. Caveolin-1 (Cav-1) is a structural membrane and scaffolding protein shown to be a key regulator of late-stage breast cancer metastasis. However, therapeutic strategies targeting Cav-1 are still lacking. Here, we demonstrate that the pharmacological activation of potassium channel Kv11.1, which is uniquely expressed in MDA-MB-231 triple negative breast cancer cells (TNBCs) but not in normal MCF-10A cells, induces the dephosphorylation of Cav-1 Tyr-14 by promoting the Ca2+-dependent stimulation of protein tyrosine phosphatase 1B (PTP1B). Consequently, the dephosphorylation of Cav-1 resulted in its disassociation from β- catenin, which enabled the accumulation of β- catenin at cell borders, where it facilitated the formation of cell-cell adhesion complexes via interactions with R-cadherin and desmosomal proteins. Kv11.1 activation-dependent Cav-1 dephosphorylation induced with NS1643 also reduced cell migration and invasion, consistent with its ability to regulate focal adhesion dynamics. Thus, this study sheds light on a novel pharmacological mechanism of promoting Cav-1 dephosphorylation, which may prove to be effective at reducing metastasis and promoting contact inhibition.
|
Authors | Ying Jiang, Vitalyi Senyuk, Ke Ma, Hui Chen, Xiang Qin, Shun Li, Yiyao Liu, Saverio Gentile, Richard D Minshall |
Journal | Cells
(Cells)
Vol. 11
Issue 15
(08 08 2022)
ISSN: 2073-4409 [Electronic] Switzerland |
PMID | 35954304
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Caveolin 1
- Cresols
- Phenylurea Compounds
- Potassium Channels
- beta Catenin
- 1,3-bis(2-hydroxy-5-trifluoromethylphenyl)urea
|
Topics |
- Caveolin 1
(metabolism)
- Cell Movement
- Cresols
- Humans
- Phenylurea Compounds
- Potassium Channels
- Triple Negative Breast Neoplasms
(drug therapy)
- beta Catenin
(metabolism)
|